Share This


Congenital nasolacrimal duct obstruction is thought to be caused by a membranous obstruction at the distal end of the nasolacrimal duct (NLD). Rarely, associated midline deformities in soft tissue and bony structures of the face are present in patients with craniofacial anomalies or genetic syndromes.

Epiphora due to NLD obstruction has been reported to occur in up to 10-15% of infants. Usually 89-96% of patients respond by the first year of life with observation, massage and antibiotics [1]. For infants who are still symptomatic at 12 months of life, the likelihood of spontaneous resolution by the second year of life is still 60% [1]. Probing will cure most unresolved cases, although its success does fall with an increasing number of attempts and with age, being rarely successful after the third attempt or after three years of age [2].

Nasal endoscopy at the time of probing provides additional information regarding the site of obstruction, minimises false passages and reduces the need for repeat procedures [3,4]. The success of simple probing is less for bilateral obstructions. Complex obstructions in the proximal part of the duct have a poorer success rate following probing than simple membranous obstructions at the end of the duct [4].

Intubation / NLD stents are advocated by many as the procedure of choice following failed probing. Studies of primary surgical management have found probing to be successful in 70-97% of cases, with many reports around 90% [4,5]. Several investigators have reported a drop off in probing success rate with increased age, generally after 24 to 36 months [2-6]. Success rates for intubation are reduced in patients with dacryocystitis, and the procedure may not be possible where a bony obstruction of the NLD is present [4].

Silicone intubation of the lacrimal system may be monocanalicular or bicanalicular. The main advantage of the former technique is in the ease of tube removal without the need of a further general anaesthetic and that the manipulation in only one canaliculus may reduce iatrogenic trauma of the lacrimal system [7]. Disadvantages of bicanalicular intubation include the need for two separate general anaesthetics, the morbidity of the stent whilst it is in situ, potential for canalicular trauma and subsequent stenosis leading to a reduced chance of a successful outcome should further surgery such as dacryocystorhinostomy (DCR) be required, and risk of iatrogenic nasolacrimal duct trauma [3,8].

It is, therefore, worthwhile considering an external DCR for children who do not respond positively to probing, rather than proceeding with intubation. Although a more invasive procedure, a DCR is invariably successful, with immediate resolution of symptoms, with the need for only one anaesthetic. Prospective studies by Hakin et al. (258 eyes, 1994) and later Rose et al. (134 eyes, 2001) demonstrated a 96% and 92% surgical success rate in external DCR without intubation; canalicular disease was associated with increased risk of failure [6].

What is an external DCR?

A skin incision is fashioned 6-8mm from the medial canthus along the anterior lacrimal crest to access the lacrimal sac. Blunt dissection follows to expose the periosteum of the frontal process of the maxilla. A rhinostomy is created removing bone medial to the lacrimal sac, from the fundus to the nasolacrimal duct in a vertical direction and from the posterior lacrimal crest forward to include the anterior lacrimal crest and the frontal process of the maxilla. The lacrimal sac is incised forming an anterior and posterior flap and nasal mucosal flaps are fashioned.

The flaps are then apposed edge to edge so that a direct passage is formed between the lacrimal sac and nose. External DCR allows inspection of the lacrimal sac and of any canalicular tissue, enabling a decision to be made on the need for either adjunctive canalicular intubation or by-pass tube. In cases of dacryocystitis, DCR should ideally be performed once an acute episode has resolved. Persistent watering without discharge requires less urgency and surgery is preferably delayed until the teenage years, as a number may have canalicular obstruction and require a bypass tube [9].

In experienced surgical hands there are few children with symptoms attributable to lacrimal obstruction who cannot be permanently and safely relieved of their symptoms by external DCR surgery.



1. MacEwen CJ, Young JD. Epiphora during the first year of life. Eye 1991;5(Pt 5):596-600.
2. Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 1987;94(6):698-705.
3. Engel JM, Hichie-Schmidt C, Khammar A, et al. Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction. J AAPOS 2007;11:183-6.
4. Paediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS. 2008;12:445-50.
5. Migliori ME, Putterman AM. Silicone intubation for the treatment of congenital lacrimal duct obstruction: successful results removing the tubes after six weeks. Ophthalmology 1988;95:792-5.
6. Hakin KN, Sullivan TJ, Sharma A, Welham RAN. Paediatric dacryocystorhinostomy. Aust NZ
J Ophthalmol 1994;22:231-5.
7. Komínek P, Cervenka S, Pniak T, et al. Monocanalicular versus bicanalicular intubation in the treatment of congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol 2011;249(11):1729-33.
8. Durso F, Hand SI Jr, Ellis FD, Helveston EM. Silicone intubation in children with nasolacrimal obstruction. J Pediatr Ophthalmol Strabismus 1980;17:389-93.
9. Heirbaut AM, Colla B, Missotten L. Silicone intubation for congenital obstruction of nasolacrimal ducts. Bull Soc Belge Ophtalmol 1990;238:87-93.

Declaration of Competing Interests: None declared.



Would you like to comment on the topics raised within this article?
Email and, once approved, your comment will be published here.


Share This
Inderpaul S Sian

FRCOphth, MCOptom, PG Cert (Clin Ed), MB ChB, BOptom (HONS), Musgrove Park Hospital, Taunton & Somerset Foundation Trust.

View Full Profile
Kim Hakin

Musgrove Park Hospital, Taunton, UK.

View Full Profile